Literature DB >> 1389707

Morphological study of defects of the atrial septum within the oval fossa: implications for transcatheter closure of left-to-right shunt.

S M Ferreira1, S Y Ho, R H Anderson.   

Abstract

OBJECTIVE: To determine the anatomical variability of the oval fossa in cases of atrial septal defect and to find out which factors might make such defects suitable or unsuitable for closure by umbrella or clamshell devices.
DESIGN: 100 specimens with defects of the atrial septum within the oval fossa were studied, especially the position of the defects within the fossa; the area of the defect in relation to the total area of the oval fossa; the shape of the rims and flap valve of the oval fossa; and the anatomical variability in the eustachian and thebesian valves.
RESULTS: The oval fossa was displaced to the mouth of the inferior caval vein in four cases; displaced to the mouth of superior caval vein in two cases; placed on the middle of the interatrial wall in 43; or placed slightly towards the inferior caval vein in 51. Because of their shape 29 of the hearts were considered to be unsuitable for transcatheter closure of the defect. This was because the defect was too large (16 hearts); the oval fossa was displaced to the mouth of the inferior caval vein (four hearts) or to the superior caval vein (two hearts); lacked its anterior rim (two hearts); lacked the posteroinferior rim (one heart); because a thick eustachian valve was displaced posteriorly forming a false posteroinferior rim (one heart); or because the strand of insertion of the floor of the oval fossa was too distant from the left atrial aspect (three hearts).
CONCLUSION: 68 hearts appeared to be ideal candidates for transcatheter closure; 3 would probably have been suitable; but 29 were unsuitable. These morphological variations might explain why the procedure has been unsuccessful in so many cases. Patients should be screened before any attempt is made at transcatheter closure.

Entities:  

Mesh:

Year:  1992        PMID: 1389707      PMCID: PMC1024841          DOI: 10.1136/hrt.67.4.316

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  7 in total

Review 1.  Right to left interatrial shunting following balloon mitral valvuloplasty.

Authors:  N Goldberg; C F Roman; S D Cha; R Weiner; V Maranhao; J Eldredge; J Fernandez
Journal:  Cathet Cardiovasc Diagn       Date:  1989-02

2.  Transcatheter closure of atrial septal defects. Past, present, and future.

Authors:  A P Rocchini
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

3.  Prevalence of patent foramen ovale in patients with stroke.

Authors:  P Lechat; J L Mas; G Lascault; P Loron; M Theard; M Klimczac; G Drobinski; D Thomas; Y Grosgogeat
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

4.  Transcatheter closure of atrial septal defects. Experimental studies.

Authors:  J E Lock; J J Rome; R Davis; S Van Praagh; S B Perry; R Van Praagh; J F Keane
Journal:  Circulation       Date:  1989-05       Impact factor: 29.690

5.  Double-umbrella closure of atrial defects. Initial clinical applications.

Authors:  J J Rome; J F Keane; S B Perry; P J Spevak; J E Lock
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

6.  Diagnostic echocardiographic features of the sinus venosus defect.

Authors:  J A Ettedgui; R D Siewers; R H Anderson; S C Park; E Pahl; J R Zuberbuhler
Journal:  Br Heart J       Date:  1990-11

7.  Right heart failure due to an inter-atrial shunt after percutaneous mitral balloon dilatation.

Authors:  Y L'Epine; G Drobinski; Y Sotirov; N Moussallem; V Voudris; M Komajda; Y Grosgogeat
Journal:  Eur Heart J       Date:  1989-03       Impact factor: 29.983

  7 in total
  14 in total

Review 1.  Anatomic-echocardiographic correlates: an introduction to normal and congenitally malformed hearts.

Authors:  S Ho; K P McCarthy; M Josen; M L Rigby
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Morphogenetic differences of secundum atrial septal defects.

Authors:  N A Blom; J Ottenkamp; T H Jongeneel; M C DeRuiter; A C Gittenberger-de Groot
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

3.  A noninvasive sizing method to choose fitted Amplatzer septal occluder by transthoracic echocardiography in patients with secundum atrial septal defects.

Authors:  Kuang-Jen Chien; Cheng-Liang Lee; Ta-Cheng Huang; Chu-Chuan Lin; Ken-Pen Weng; Shih-Hui Huang; Kai-Sheng Hsieh
Journal:  Heart Vessels       Date:  2007-07-20       Impact factor: 2.037

Review 4.  Computer-aided interactive three-dimensional reconstruction of the embryonic human heart.

Authors:  S Whiten; S D Smart; J C McLachlan; J F Aiton
Journal:  J Anat       Date:  1998-10       Impact factor: 2.610

5.  Closure of atrial septal defects by transcatheter devices.

Authors:  A G Magee; S A Qureshi
Journal:  Pediatr Cardiol       Date:  1997 Sep-Oct       Impact factor: 1.655

6.  Transcatheter closure of secundum atrial septal defects with the atrial septal defect occlusion system (ASDOS): initial experience in children.

Authors:  G Hausdorf; M Schneider; B Franzbach; C Kampmann; K Kargus; B Goeldner
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

7.  Patent foramen ovale in adult life.

Authors:  P T Wilmshurst; M A de Belder
Journal:  Br Heart J       Date:  1994-03

Review 8.  [Interventions in congenital heart disease and their sequelae in adults].

Authors:  A A Schmaltz; U Neudorf; S Sack; O Galal
Journal:  Herz       Date:  1999-06       Impact factor: 1.443

9.  Dynamic morphology of the secundum atrial septal defect evaluated by three dimensional transoesophageal echocardiography.

Authors:  Y V Maeno; L N Benson; P R McLaughlin; C Boutin
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

10.  Predictors of successful transcatheter closure of atrial septal defect by cardiac magnetic resonance imaging.

Authors:  K Durongpisitkul; N L Tang; J Soongswang; D Laohaprasitiporn; A Nanal
Journal:  Pediatr Cardiol       Date:  2003-12-15       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.